VRK2 Targeting Boosts Anti-PD-1 Therapy via MYC
In a groundbreaking development that could reshape the future of immunotherapy for liver cancer, researchers have discovered a novel molecular ...
In a groundbreaking development that could reshape the future of immunotherapy for liver cancer, researchers have discovered a novel molecular ...
In a groundbreaking study, scientists have turned their attention to the molecular intricacies of head and neck squamous cell carcinoma ...
A groundbreaking clinical trial has been launched to assess the safety and effectiveness of afatinib, a promising targeted therapy, in ...
A groundbreaking study from Johns Hopkins University School of Medicine and the Johns Hopkins Kimmel Cancer Center has unveiled that ...
In the ongoing quest to conquer gastroesophageal adenocarcinoma, a malignancy notorious for its aggressive behavior and dismal prognosis, scientific efforts ...
The landscape of pediatric oncology is fraught with challenges, particularly when addressing the aggressiveness of Rhabdomyosarcoma (RMS), a malignant soft ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine